25 XP   0   0   10

Zivo Bioscience Inc
Buy, Hold or Sell?

Let's analyse Zivo Bioscience Inc together

PenkeI guess you are interested in Zivo Bioscience Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Zivo Bioscience Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Zivo Bioscience Inc

I send you an email if I find something interesting about Zivo Bioscience Inc.

Quick analysis of Zivo Bioscience Inc (30 sec.)










What can you expect buying and holding a share of Zivo Bioscience Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.79
Expected worth in 1 year
$-1.58
How sure are you?
27.5%

+ What do you gain per year?

Total Gains per Share
$-0.79
Return On Investment
-10.2%

For what price can you sell your share?

Current Price per Share
$7.75
Expected price per share
$4.44 - $10.21
How sure are you?
50%

1. Valuation of Zivo Bioscience Inc (5 min.)




Live pricePrice per Share (EOD)

$7.75

Intrinsic Value Per Share

$-15.32 - $-8.80

Total Value Per Share

$-16.11 - $-9.59

2. Growth of Zivo Bioscience Inc (5 min.)




Is Zivo Bioscience Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$2.2m$2.6m-$4.6m-229.1%

How much money is Zivo Bioscience Inc making?

Current yearPrevious yearGrowGrow %
Making money-$1.9m-$2.4m$526k27.1%
Net Profit Margin-20,691.2%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Zivo Bioscience Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#920 / 1031

Most Revenue
#700 / 1031

Most Profit
#313 / 1031

Most Efficient
#983 / 1031

What can you expect buying and holding a share of Zivo Bioscience Inc? (5 min.)

Welcome investor! Zivo Bioscience Inc's management wants to use your money to grow the business. In return you get a share of Zivo Bioscience Inc.

What can you expect buying and holding a share of Zivo Bioscience Inc?

First you should know what it really means to hold a share of Zivo Bioscience Inc. And how you can make/lose money.

Speculation

The Price per Share of Zivo Bioscience Inc is $7.75. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Zivo Bioscience Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Zivo Bioscience Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.79. Based on the TTM, the Book Value Change Per Share is $-0.20 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.16 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Zivo Bioscience Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.69-8.9%-0.70-9.0%-0.79-10.2%-0.80-10.3%-0.72-9.3%
Usd Book Value Change Per Share-0.40-5.2%-0.20-2.5%-0.16-2.1%0.364.7%0.070.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.40-5.2%-0.20-2.5%-0.16-2.1%0.364.7%0.070.9%
Usd Price Per Share1.20-2.00-3.28-1.72-0.91-
Price to Earnings Ratio-0.44--0.71--1.07--0.64--0.33-
Price-to-Total Gains Ratio-3.00--2.74--2.70-5.84-2.86-
Price to Book Ratio-1.51--2.97--160.81--32.37--16.20-
Price-to-Total Gains Ratio-3.00--2.74--2.70-5.84-2.86-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share7.75
Number of shares129
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.200.36
Usd Total Gains Per Share-0.200.36
Gains per Quarter (129 shares)-25.4946.62
Gains per Year (129 shares)-101.95186.48
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-102-1120186176
20-204-2140373362
30-306-3160559548
40-408-4180746734
50-510-5200932920
60-612-622011191106
70-714-724013051292
80-816-826014921478
90-918-928016781664
100-1020-1030018651850

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%2.038.00.05.0%6.075.00.07.4%
Book Value Change Per Share1.03.00.025.0%4.08.00.033.3%7.013.00.035.0%11.028.01.027.5%21.053.07.025.9%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.081.00.0%
Total Gains per Share1.03.00.025.0%4.08.00.033.3%7.013.00.035.0%11.028.01.027.5%21.053.07.025.9%

Fundamentals of Zivo Bioscience Inc

About Zivo Bioscience Inc

ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.

Fundamental data was last updated by Penke on 2024-03-22 13:18:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Zivo Bioscience Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Zivo Bioscience Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Zivo Bioscience Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -16,174.1% means that $-161.74 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Zivo Bioscience Inc:

  • The MRQ is -16,174.1%. The company is making a huge loss. -2
  • The TTM is -20,691.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-16,174.1%TTM-20,691.2%+4,517.1%
TTM-20,691.2%YOY--20,691.2%
TTM-20,691.2%5Y-4,774.5%-15,916.7%
5Y-4,774.5%10Y-2,548.7%-2,225.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-16,174.1%-159.2%-16,014.9%
TTM-20,691.2%-202.3%-20,488.9%
YOY--263.0%+263.0%
5Y-4,774.5%-452.4%-4,322.1%
10Y-2,548.7%-589.0%-1,959.7%
1.1.2. Return on Assets

Shows how efficient Zivo Bioscience Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Zivo Bioscience Inc to the Biotechnology industry mean.
  • -343.4% Return on Assets means that Zivo Bioscience Inc generated $-3.43 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Zivo Bioscience Inc:

  • The MRQ is -343.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -224.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-343.4%TTM-224.2%-119.3%
TTM-224.2%YOY-61.3%-162.8%
TTM-224.2%5Y-796.0%+571.8%
5Y-796.0%10Y-657.3%-138.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-343.4%-12.5%-330.9%
TTM-224.2%-12.2%-212.0%
YOY-61.3%-11.2%-50.1%
5Y-796.0%-13.3%-782.7%
10Y-657.3%-14.6%-642.7%
1.1.3. Return on Equity

Shows how efficient Zivo Bioscience Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Zivo Bioscience Inc to the Biotechnology industry mean.
  • 0.0% Return on Equity means Zivo Bioscience Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Zivo Bioscience Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-63.2%+63.2%
TTM-5Y-17.8%+17.8%
5Y-17.8%10Y-8.9%-8.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--16.0%+16.0%
TTM--15.8%+15.8%
YOY-63.2%-13.9%-49.3%
5Y-17.8%-18.2%+0.4%
10Y-8.9%-19.1%+10.2%

1.2. Operating Efficiency of Zivo Bioscience Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Zivo Bioscience Inc is operating .

  • Measures how much profit Zivo Bioscience Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Zivo Bioscience Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Zivo Bioscience Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-11,397.0%+11,397.0%
TTM-11,397.0%YOY--11,397.0%
TTM-11,397.0%5Y-2,880.9%-8,516.1%
5Y-2,880.9%10Y-1,564.1%-1,316.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--299.5%+299.5%
TTM-11,397.0%-208.5%-11,188.5%
YOY--280.2%+280.2%
5Y-2,880.9%-459.9%-2,421.0%
10Y-1,564.1%-596.9%-967.2%
1.2.2. Operating Ratio

Measures how efficient Zivo Bioscience Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 161.73 means that the operating costs are $161.73 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Zivo Bioscience Inc:

  • The MRQ is 161.728. The company is inefficient in keeping operating costs low. -1
  • The TTM is 186.830. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ161.728TTM186.830-25.102
TTM186.830YOY-+186.830
TTM186.8305Y43.436+143.394
5Y43.43610Y22.676+20.759
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ161.7282.817+158.911
TTM186.8303.181+183.649
YOY-3.609-3.609
5Y43.4365.554+37.882
10Y22.6767.396+15.280

1.3. Liquidity of Zivo Bioscience Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Zivo Bioscience Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.15 means the company has $0.15 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Zivo Bioscience Inc:

  • The MRQ is 0.154. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.310. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.154TTM0.310-0.156
TTM0.310YOY1.916-1.606
TTM0.3105Y0.912-0.602
5Y0.91210Y0.481+0.431
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1543.987-3.833
TTM0.3104.440-4.130
YOY1.9165.569-3.653
5Y0.9126.158-5.246
10Y0.4816.492-6.011
1.3.2. Quick Ratio

Measures if Zivo Bioscience Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Zivo Bioscience Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.10 means the company can pay off $0.10 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Zivo Bioscience Inc:

  • The MRQ is 0.101. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.163. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.101TTM0.163-0.062
TTM0.163YOY1.814-1.651
TTM0.1635Y0.703-0.540
5Y0.70310Y0.373+0.330
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1013.653-3.552
TTM0.1634.158-3.995
YOY1.8145.515-3.701
5Y0.7036.012-5.309
10Y0.3736.206-5.833

1.4. Solvency of Zivo Bioscience Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Zivo Bioscience Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Zivo Bioscience Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 4.97 means that Zivo Bioscience Inc assets are financed with 496.9% credit (debt) and the remaining percentage (100% - 496.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Zivo Bioscience Inc:

  • The MRQ is 4.969. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 3.615. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ4.969TTM3.615+1.354
TTM3.615YOY0.609+3.006
TTM3.6155Y39.646-36.031
5Y39.64610Y42.299-2.653
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.9690.336+4.633
TTM3.6150.330+3.285
YOY0.6090.267+0.342
5Y39.6460.367+39.279
10Y42.2990.378+41.921
1.4.2. Debt to Equity Ratio

Measures if Zivo Bioscience Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Zivo Bioscience Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Zivo Bioscience Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY0.760-0.760
TTM-5Y0.226-0.226
5Y0.22610Y0.113+0.113
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.376-0.376
TTM-0.398-0.398
YOY0.7600.334+0.426
5Y0.2260.431-0.205
10Y0.1130.476-0.363

2. Market Valuation of Zivo Bioscience Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Zivo Bioscience Inc generates.

  • Above 15 is considered overpriced but always compare Zivo Bioscience Inc to the Biotechnology industry mean.
  • A PE ratio of -0.44 means the investor is paying $-0.44 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Zivo Bioscience Inc:

  • The EOD is -2.820. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.437. Based on the earnings, the company is expensive. -2
  • The TTM is -0.707. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.820MRQ-0.437-2.383
MRQ-0.437TTM-0.707+0.270
TTM-0.707YOY-1.067+0.361
TTM-0.7075Y-0.638-0.068
5Y-0.63810Y-0.334-0.304
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.820-2.697-0.123
MRQ-0.437-2.422+1.985
TTM-0.707-2.709+2.002
YOY-1.067-4.116+3.049
5Y-0.638-6.257+5.619
10Y-0.334-6.478+6.144
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Zivo Bioscience Inc:

  • The EOD is -7.519. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.164. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.083. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.519MRQ-1.164-6.355
MRQ-1.164TTM-1.083-0.081
TTM-1.083YOY-1.502+0.419
TTM-1.0835Y-0.919-0.164
5Y-0.91910Y-0.509-0.410
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-7.519-3.344-4.175
MRQ-1.164-2.939+1.775
TTM-1.083-3.486+2.403
YOY-1.502-5.592+4.090
5Y-0.919-8.464+7.545
10Y-0.509-8.872+8.363
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Zivo Bioscience Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -1.51 means the investor is paying $-1.51 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Zivo Bioscience Inc:

  • The EOD is -9.759. Based on the equity, the company is expensive. -2
  • The MRQ is -1.511. Based on the equity, the company is expensive. -2
  • The TTM is -2.965. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-9.759MRQ-1.511-8.248
MRQ-1.511TTM-2.965+1.454
TTM-2.965YOY-160.811+157.846
TTM-2.9655Y-32.370+29.405
5Y-32.37010Y-16.200-16.170
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-9.7592.198-11.957
MRQ-1.5112.042-3.553
TTM-2.9652.121-5.086
YOY-160.8112.907-163.718
5Y-32.3703.682-36.052
10Y-16.2004.114-20.314
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Zivo Bioscience Inc.

3.1. Institutions holding Zivo Bioscience Inc

Institutions are holding 0.078% of the shares of Zivo Bioscience Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-06-30Armistice Capital, LLC9.37860.0359102387010238700
2023-06-30Geode Capital Management, LLC2.49870.0001272788-3835-1.3864
2023-06-30Vanguard Group Inc1.0656011633069916.3939
2023-06-30Wells Fargo & Co0.103701131820.0177
2023-09-30Verdence Capital Advisors LLC0.09160.00141000000
2023-09-30Bartlett & Co. LLC0.00920100000
2023-06-30PNC Financial Services Group Inc0.0058062900
2023-06-30Royal Bank of Canada0.001601701700
2023-06-30JPMorgan Chase & Co0.000901001000
2023-06-30Bourgeon Capital Management LLC0.000303100
2023-06-30Belpointe Asset Management LLC000-95-100
2023-06-30UBS Group AG000-850-100
2023-09-30BlackRock Inc000-5021-100
2023-06-30Bank of America Corp000-28-100
Total 13.1560.03741436236+1021304+71.1%

3.2. Funds holding Zivo Bioscience Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30Northern Trust Extended Eq Market Idx0.04930.0001538200
2023-09-30SSgA U.S. Extended Market Index Class I0.02560.0002280000
Total 0.07490.0003818200.0%

3.3. Insider Transactions

Insiders are holding 26.204% of the shares of Zivo Bioscience Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-06-02Mark E StromeBUY400004.99

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Zivo Bioscience Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.400-0.198-51%-0.161-60%0.361-211%0.066-702%
Book Value Per Share---0.794-0.737-7%0.951-184%-1.605+102%-3.079+288%
Current Ratio--0.1540.310-50%1.916-92%0.912-83%0.481-68%
Debt To Asset Ratio--4.9693.615+37%0.609+716%39.646-87%42.299-88%
Debt To Equity Ratio----0%0.760-100%0.226-100%0.113-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.687-0.700+2%-0.787+15%-0.795+16%-0.720+5%
Free Cash Flow Per Share---0.258-0.522+103%-0.553+115%-0.427+66%-0.364+41%
Free Cash Flow To Equity Per Share---0.436-0.137-69%-0.505+16%0.052-939%0.024-1913%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.995+1%
Intrinsic Value_10Y_max---8.800--------
Intrinsic Value_10Y_min---15.318--------
Intrinsic Value_1Y_max---1.374--------
Intrinsic Value_1Y_min---2.007--------
Intrinsic Value_3Y_max---3.754--------
Intrinsic Value_3Y_min---5.658--------
Intrinsic Value_5Y_max---5.681--------
Intrinsic Value_5Y_min---8.871--------
Market Cap21526710.000+85%3333168.0005555280.000-40%9096771.000-63%5726226.446-42%3006258.900+11%
Net Profit Margin---161.741-206.912+28%--100%-47.745-70%-25.487-84%
Operating Margin----113.9700%-0%-28.8090%-15.6410%
Operating Ratio--161.728186.830-13%-+100%43.436+272%22.676+613%
Pb Ratio-9.759-546%-1.511-2.965+96%-160.811+10542%-32.370+2042%-16.200+972%
Pe Ratio-2.820-546%-0.437-0.707+62%-1.067+144%-0.638+46%-0.334-23%
Price Per Share7.750+85%1.2002.000-40%3.275-63%1.718-30%0.911+32%
Price To Free Cash Flow Ratio-7.519-546%-1.164-1.083-7%-1.502+29%-0.919-21%-0.509-56%
Price To Total Gains Ratio-19.362-546%-2.998-2.742-9%-2.705-10%5.843-151%2.855-205%
Quick Ratio--0.1010.163-38%1.814-94%0.703-86%0.373-73%
Return On Assets---3.434-2.242-35%-0.613-82%-7.960+132%-6.573+91%
Return On Equity----0%-0.6320%-0.1780%-0.0890%
Total Gains Per Share---0.400-0.198-51%-0.161-60%0.361-211%0.066-702%
Usd Book Value---2205843.000-2046594.750-7%2641563.750-184%-4244551.750+92%-8445182.450+283%
Usd Book Value Change Per Share---0.400-0.198-51%-0.161-60%0.361-211%0.066-702%
Usd Book Value Per Share---0.794-0.737-7%0.951-184%-1.605+102%-3.079+288%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.687-0.700+2%-0.787+15%-0.795+16%-0.720+5%
Usd Free Cash Flow---715733.000-1449973.250+103%-1535621.750+115%-1252071.250+75%-1044085.650+46%
Usd Free Cash Flow Per Share---0.258-0.522+103%-0.553+115%-0.427+66%-0.364+41%
Usd Free Cash Flow To Equity Per Share---0.436-0.137-69%-0.505+16%0.052-939%0.024-1913%
Usd Market Cap21526710.000+85%3333168.0005555280.000-40%9096771.000-63%5726226.446-42%3006258.900+11%
Usd Price Per Share7.750+85%1.2002.000-40%3.275-63%1.718-30%0.911+32%
Usd Profit---1908547.000-1944295.750+2%-2470318.000+29%-2371885.650+24%-2031649.025+6%
Usd Revenue--11800.0006912.500+71%-+100%1001382.500-99%503907.400-98%
Usd Total Gains Per Share---0.400-0.198-51%-0.161-60%0.361-211%0.066-702%
 EOD+6 -2MRQTTM+11 -19YOY+11 -205Y+14 -1710Y+18 -14

4.2. Fundamental Score

Let's check the fundamental score of Zivo Bioscience Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.820
Price to Book Ratio (EOD)Between0-1-9.759
Net Profit Margin (MRQ)Greater than0-161.741
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.101
Current Ratio (MRQ)Greater than10.154
Debt to Asset Ratio (MRQ)Less than14.969
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-3.434
Total1/10 (10.0%)

4.3. Technical Score

Let's check the technical score of Zivo Bioscience Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.375
Ma 20Greater thanMa 508.607
Ma 50Greater thanMa 1008.377
Ma 100Greater thanMa 2005.056
OpenGreater thanClose7.680
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets556
Total Liabilities2,762
Total Stockholder Equity-2,206
 As reported
Total Liabilities 2,762
Total Stockholder Equity+ -2,206
Total Assets = 556

Assets

Total Assets556
Total Current Assets425
Long-term Assets130
Total Current Assets
Cash And Cash Equivalents 274
Net Receivables 4
Total Current Assets  (as reported)425
Total Current Assets  (calculated)278
+/- 147
Long-term Assets
Property Plant Equipment 98
Long-term Assets Other 32
Long-term Assets  (as reported)130
Long-term Assets  (calculated)130
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,762
Long-term Liabilities0
Total Stockholder Equity-2,206
Total Current Liabilities
Short-term Debt 346
Short Long Term Debt 240
Accounts payable 993
Other Current Liabilities 1,422
Total Current Liabilities  (as reported)2,762
Total Current Liabilities  (calculated)3,002
+/- 240
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock2
Retained Earnings -123,582
Other Stockholders Equity 121,373
Total Stockholder Equity (as reported)-2,206
Total Stockholder Equity (calculated)-2,206
+/-0
Other
Capital Stock2
Cash and Short Term Investments 274
Common Stock Shares Outstanding 1,820
Liabilities and Stockholders Equity 556
Net Debt 72
Net Invested Capital -1,966
Net Working Capital -2,336
Property Plant and Equipment Gross 98
Short Long Term Debt Total 346



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-09-301999-06-30
> Total Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
10
1,067
48
53
53
155
45
660
660
488
629
322
190
394
495
275
275
460
465
435
435
403
631
402
402
393
319
340
340
391
366
463
417
356
229
234
221
496
2,011
2,174
1,784
1,541
1,593
102
102
119
102
73
350
91
750
737
1,239
206
1,429
4,210
2,787
740
279
412
104
112
70
369
179
223
130
220
649
11,104
10,972
8,990
8,990
5,865
3,971
2,123
1,128
710
2,102
556
5562,1027101,1282,1233,9715,8658,9908,99010,97211,104649220130223179369701121044122797402,7874,2101,4292061,23973775091350731021191021021,5931,5411,7842,1742,011496221234229356417463366391340340319393402402631403435435465460275275495394190322629488660660451555353481,067101000000000000000000
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
10
648
34
30
30
132
20
621
621
327
433
56
147
139
246
34
34
171
139
108
108
91
312
95
95
92
32
37
37
63
92
250
181
173
62
91
97
495
519
689
305
69
127
33
33
63
52
29
312
60
615
520
1,056
57
1,315
332
187
740
279
412
104
112
70
369
179
223
130
168
458
11,062
10,935
8,960
8,960
5,601
3,729
1,902
928
530
1,948
425
4251,9485309281,9023,7295,6018,9608,96010,93511,062458168130223179369701121044122797401873321,315571,0565206156031229526333331276930568951949597916217318125092633737329295953129110810813917134342461391475643332762162120132303034648101000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
609
1
17
17
118
11
604
604
294
380
10
114
51
162
5
5
26
5
0
2
26
119
0
211
46
2
16
16
10
60
226
132
96
7
47
26
255
281
493
97
31
102
1
1
16
20
17
259
26
585
507
1,008
24
1,225
317
98
678
228
389
4
44
15
346
10
119
55
138
232
10,903
10,803
8,902
8,902
5,084
3,386
1,799
209
21
1,485
274
2741,485212091,7993,3865,0848,9028,90210,80310,903232138551191034615444389228678983171,225241,008507585262591720161110231974932812552647796132226601016162462110119262052655162511141038029460460411118171716091100000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
0
0
0
0
0
0
0
0
13
13
18
12
2
2
33
51
49
49
27
8
0
49
30
-2
0
3
0
0
0
0
0
0
0
0
118
118
118
118
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20
0
0
0
0
42
0
0
0
0
0
0
0
3
3
4
433000000042000020000000000000000000000001181181181180000000030-23049082749495133221218131300000000111100000000000000000
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
29
22
11
11
11
7
13
13
28
27
3
22
49
36
0
5
42
14
15
15
0
148
91
91
0
18
11
11
19
17
24
48
78
55
44
37
87
97
72
90
38
25
32
32
47
32
12
53
34
29
13
49
33
91
15
89
62
50
23
99
69
54
23
149
104
75
30
226
159
132
0
58
517
343
102
720
506
461
0
0461506720102343517580132159226307510414923546999235062891591334913293453123247323225389072978737445578482417191111180919114801515144250364922327281313711111122291100000000000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
744
419
14
23
23
22
25
39
39
160
196
266
43
255
248
0
241
289
326
327
327
313
319
307
307
301
287
303
303
328
274
214
237
183
166
143
124
1
1,492
1,486
1,479
1,473
1,466
69
69
56
50
44
38
31
135
217
183
148
114
3,878
2,600
0
0
0
0
0
0
0
0
0
0
52
191
42
36
30
30
264
243
221
200
180
154
130
130154180200221243264303036421915200000000002,6003,878114148183217135313844505669691,4661,4731,4791,4861,492112414316618323721427432830330328730130730731931332732732628924102482554326619616039392522232314419744000000000000000000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
17
17
28
46
132
21
122
115
0
108
156
194
195
195
181
187
177
177
168
154
170
170
160
125
84
66
52
36
13
0
0
100
94
88
81
75
69
69
56
50
44
38
31
25
19
13
6
0
0
0
0
0
0
0
0
0
0
0
0
0
49
44
39
33
27
27
232
211
189
168
145
122
98
98122145168189211232272733394449000000000000061319253138445056696975818894100001336526684125160170170154168177177187181195195194156108011512221132462817173000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
744
405
0
14
14
14
13
13
13
13
12
12
13
12
11
11
11
11
10
0
10
0
9
0
10
9
8
8
8
8
7
7
7
7
6
6
0
0
1,391
1,391
1,391
1,391
1,391
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000001,3911,3911,3911,3911,391006677778888910090100101111111112131212131313131414140405744000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
170
131
131
130
124
1
1,392
1,391
1,391
1,391
1,391
0
0
0
0
0
0
0
110
198
170
142
114
3,878
2,600
0
0
0
0
0
0
0
0
0
0
3
146
3
3
3
32
32
32
32
0
0
0
0
000032323232333146300000000002,6003,87811414217019811000000001,3911,3911,3911,3911,392112413013113117000000000000000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
142
114
3,878
2,600
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000002,6003,87811414200000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
0
0
0
2
0
0
0
0
0
0
0
0
0
0
0
46
46
685
607
1,156
1,156
1,652
1,482
1,250
1,250
1,208
1,195
1,154
1,172
1,145
1,198
1,030
1,030
716
881
955
955
1,023
3,859
4,187
4,187
1,055
1,201
1,292
1,292
1,495
1,663
2,495
2,872
3,498
3,578
4,190
5,098
9,107
12,548
11,768
6,667
6,548
9,636
6,471
6,471
8,074
8,775
9,570
10,465
11,206
13,519
14,359
16,574
16,776
19,467
20,515
22,346
19,578
21,850
22,694
24,803
11,271
10,973
8,708
9,327
10,216
11,221
11,531
12,073
3,771
3,551
2,948
2,948
2,854
2,447
2,134
2,870
3,855
3,196
2,762
2,7623,1963,8552,8702,1342,4472,8542,9482,9483,5513,77112,07311,53111,22110,2169,3278,70810,97311,27124,80322,69421,85019,57822,34620,51519,46716,77616,57414,35913,51911,20610,4659,5708,7758,0746,4716,4719,6366,5486,66711,76812,5489,1075,0984,1903,5783,4982,8722,4951,6631,4951,2921,2921,2011,0554,1874,1873,8591,0239559558817161,0301,0301,1981,1451,1721,1541,1951,2081,2501,2501,4821,6521,1561,156607685464600000000000200000
   > Total Current Liabilities 
0
0
0
0
0
2
0
0
0
0
0
0
0
0
0
0
0
46
46
685
607
1,156
1,156
1,652
1,482
1,250
1,250
1,165
1,146
1,092
1,172
1,072
625
679
679
517
647
685
685
597
3,470
3,775
3,775
797
792
781
781
859
1,009
1,788
2,054
2,532
2,458
3,361
4,620
8,707
12,006
10,877
5,656
5,912
9,155
6,234
6,234
7,193
8,333
4,971
5,579
6,336
6,701
11,182
2,520
2,617
18,817
4,561
5,841
19,578
21,850
22,694
24,803
11,271
10,973
8,708
9,327
10,094
11,100
11,394
11,941
3,642
3,548
2,948
2,948
2,697
2,315
2,028
2,791
3,804
3,174
2,762
2,7623,1743,8042,7912,0282,3152,6972,9482,9483,5483,64211,94111,39411,10010,0949,3278,70810,97311,27124,80322,69421,85019,5785,8414,56118,8172,6172,52011,1826,7016,3365,5794,9718,3337,1936,2346,2349,1555,9125,65610,87712,0068,7074,6203,3612,4582,5322,0541,7881,0098597817817927973,7753,7753,4705976856856475176796796251,0721,1721,0921,1461,1651,2501,2501,4821,6521,1561,156607685464600000000000200000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20
20
585
585
1,266
710
694
694
727
691
472
693
440
26
26
26
6
23
22
22
9
98
158
158
243
180
161
161
84
263
315
57
57
123
741
1,425
1,551
1,532
1,619
1,559
2,227
2,851
3,769
3,769
4,364
5,283
1,562
1,992
2,621
2,723
7,133
516
656
16,530
1,884
2,039
15,928
17,896
18,155
19,713
7,637
7,460
5,280
5,226
5,231
5,289
5,219
5,371
330
261
0
255
676
472
339
881
1,458
1,480
346
3461,4801,45888133947267625502613305,3715,2195,2895,2315,2265,2807,4607,63719,71318,15517,89615,9282,0391,88416,5306565167,1332,7232,6211,9921,5625,2834,3643,7693,7692,8512,2271,5591,6191,5321,5511,42574112357573152638416116118024315815898922222362626264406934726917276946947101,26658558520200000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,133
516
14,815
16,186
1,490
1,490
15,747
17,716
17,978
19,713
7,637
7,460
5,280
5,226
5,231
5,289
5,189
5,339
304
240
240
799
589
380
240
778
1,352
1,370
240
2401,3701,3527782403805897992402403045,3395,1895,2895,2315,2265,2807,4607,63719,71317,97817,71615,7471,4901,49016,18614,8155167,133000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
2
0
0
0
0
0
0
0
0
0
0
0
27
27
88
214
407
407
35
59
160
160
209
243
501
85
425
468
0
533
463
576
509
509
528
480
542
542
492
483
456
456
619
609
661
655
723
875
939
915
803
939
483
600
682
483
1,226
1,226
1,187
1,219
1,326
1,250
1,111
824
666
769
760
635
542
1,132
450
393
422
803
1,166
962
1,372
1,824
1,486
1,901
1,560
1,735
918
729
654
654
408
607
491
670
1,273
644
993
9936441,2736704916074086546547299181,7351,5601,9011,4861,8241,3729621,1668034223934501,1325426357607696668241,1111,2501,3261,2191,1871,2261,226483682600483939803915939875723655661609619456456483492542542480528509509576463533046842585501243209160160593540740721488272700000000000200000
       Other Current Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19
19
431
230
164
164
351
713
396
396
229
211
120
393
3
131
0
119
48
0
152
41
61
2,818
2,931
2,865
0
75
149
149
100
95
784
1,313
1,724
1,432
1,653
2,253
5,693
8,850
8,036
2,672
2,079
4,768
1,239
1,239
1,641
1,831
2,084
2,336
2,604
3,154
3,383
1,235
1,201
1,652
2,135
2,671
3,200
3,561
4,117
4,287
2,469
2,550
2,055
2,277
2,344
2,524
2,679
2,834
362
527
1,475
2,038
1,614
1,236
1,198
1,239
1,312
1,290
1,422
1,4221,2901,3121,2391,1981,2361,6142,0381,4755273622,8342,6792,5242,3442,2772,0552,5502,4694,2874,1173,5613,2002,6712,1351,6521,2011,2353,3833,1542,6042,3362,0841,8311,6411,2391,2394,7682,0792,6728,0368,8505,6932,2531,6531,4321,7241,313784951001491497502,8652,9312,818614115204811901313393120211229396396713351164164230431191900000000000000000
   > Long-term Liabilities 
0
0
0
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
27
108
234
0
992
1,301
769
0
854
43
49
63
779
73
573
0
351
200
234
270
270
426
389
413
413
258
409
511
511
636
654
707
818
966
1,121
829
478
399
543
891
1,010
636
481
237
237
881
442
4,599
4,887
4,869
6,818
3,176
14,053
14,159
650
15,954
16,505
16,378
18,289
18,577
20,516
8,803
8,423
6,653
7,050
122
122
137
132
128
3
0
910
157
132
106
79
51
22
0
0225179106132157910031281321371221227,0506,6538,4238,80320,51618,57718,28916,37816,50515,95465014,15914,0533,1766,8184,8694,8874,5994428812372374816361,0108915433994788291,12196681870765463651151140925841341338942627027023420035105737377963494385407691,301992023410827000000000000200000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
255
281
0
0
0
0
0
0
0
0
8,036
2,672
26
28
141
646
881
442
1,225
4,887
4,869
6,818
3,176
14,053
0
0
0
0
0
0
0
0
0
0
0
0
122
122
122
122
0
0
0
0
0
0
0
0
0
0
0
0000000000012212212212200000000000014,0533,1766,8184,8694,8871,22544288164614128262,6728,0360000000028125500000000000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
142
114
3,878
2,600
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000002,6003,87811414200000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
253
247
235
235
235
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000023523523524725300000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
228
224
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
142
114
3,878
2,600
0
0
0
0
0
0
0
0
0
0
0
143
0
0
0
0
0
0
0
0
0
0
0
00000000000143000000000002,6003,878114142000000000000000000000022422800000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
-41
-41
-2
-44
-44
-45
-46
-47
-48
-49
-49
0
-52
-52
-36
-36
382
-559
-1,103
-1,103
-1,497
-1,437
-590
-590
-720
-566
-833
-982
-751
-704
0
-755
-256
-416
-520
-520
-620
-3,228
-3,786
-3,786
-662
-882
-952
-952
-1,104
-1,297
-2,031
-2,454
-3,142
-3,349
-3,956
-4,877
-8,610
-10,537
-9,594
-4,883
-5,007
-8,043
-6,369
-6,369
-7,954
-8,673
-9,497
-10,116
-11,115
-12,769
-13,621
-15,335
-16,571
-18,038
-16,304
-19,559
-18,838
-21,572
-22,282
-24,700
-11,159
-10,903
-8,338
-9,148
-9,993
-11,091
-11,311
-11,424
7,333
7,421
6,042
6,042
3,010
1,524
-11
-1,742
-3,145
-1,094
-2,206
-2,206-1,094-3,145-1,742-111,5243,0106,0426,0427,4217,333-11,424-11,311-11,091-9,993-9,148-8,338-10,903-11,159-24,700-22,282-21,572-18,838-19,559-16,304-18,038-16,571-15,335-13,621-12,769-11,115-10,116-9,497-8,673-7,954-6,369-6,369-8,043-5,007-4,883-9,594-10,537-8,610-4,877-3,956-3,349-3,142-2,454-2,031-1,297-1,104-952-952-882-662-3,786-3,786-3,228-620-520-520-416-256-7550-704-751-982-833-566-720-590-590-1,437-1,497-1,103-1,103-559382-36-36-52-520-49-49-48-47-46-45-44-44-2-41-41000
   Common Stock
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
10
10
12
12
12
12
15
24
27
27
34
36
39
33
42
44
0
44
54
55
59
59
71
78
79
79
89
90
93
93
97
98
100
100
100
103
105
105
108
114
117
123
127
129
129
129
131
132
132
133
133
137
137
137
139
141
141
141
160
169
180
186
342
358
397
404
407
407
413
421
9
9
9
9
9
9
9
9
9
2
2
2299999999942141340740740439735834218618016916014114114113913713713713313313213213112912912912712311711410810510510310010010098979393908979797871595955544404442333936342727241512121212101011111111111111000
   Retained Earnings Total Equity0000000000-103,128-101,283-99,064-97,171-93,668-92,501-89,958-85,826-84,045-81,505-78,4480-71,232-67,659-63,812-59,932-57,064-55,636-53,774-52,542-51,401-49,108-47,714-46,697-45,222-43,212-41,925-42,652-39,311-38,644-42,60600000000-27,853-27,31100000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 00000000000-1000-100-100-100-100-100-100-100-100-100-100-100-100-100-94-88-81-75-69-63-56-50-44-31-31-25-19-13-6-3-3-18-303-280-264-247-229-188-153-138-138-127-113-101-101-91-83-69-69-60-52-9-9-67-23-368-9-83-115-623-62300-30-30000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
26,110
26,458
0
0
0
0
0
0
0
0
32,895
33,638
34,177
34,480
35,427
35,725
37,137
37,892
38,085
38,859
40,154
39,636
40,016
40,164
40,354
41,753
47,367
47,958
52,233
0
55,986
56,619
72,544
74,565
81,223
82,949
83,268
85,673
87,340
89,438
110,452
0
0
0
0
0
0
0
0
0
0
0000000000110,45289,43887,34085,67383,26882,94981,22374,56572,54456,61955,986052,23347,95847,36741,75340,35440,16440,01639,63640,15438,85938,08537,89237,13735,72535,42734,48034,17733,63832,8950000000026,45826,11000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
41
41
42
44
44
45
46
47
48
49
49
51
52
52
494
494
3,291
3,301
3,343
3,343
3,588
8,032
10,391
10,391
11,901
12,655
13,063
10,706
14,225
15,009
0
15,386
17,085
17,199
17,481
17,481
18,398
16,874
15,645
15,645
16,787
17,168
25,624
25,624
26,263
26,646
27,360
28,014
28,090
28,457
28,752
28,472
29,471
32,219
32,902
33,650
34,195
34,505
35,459
35,459
37,181
37,942
38,142
38,922
40,223
39,711
40,097
40,252
40,447
41,853
47,467
48,058
52,333
53,710
56,086
56,719
72,644
74,665
81,323
83,049
83,368
85,773
87,340
89,538
110,452
112,474
0
114,260
115,328
114,679
115,784
116,027
116,694
120,577
121,373
121,373120,577116,694116,027115,784114,679115,328114,2600112,474110,45289,53887,34085,77383,36883,04981,32374,66572,64456,71956,08653,71052,33348,05847,46741,85340,44740,25240,09739,71140,22338,92238,14237,94237,18135,45935,45934,50534,19533,65032,90232,21929,47128,47228,75228,45728,09028,01427,36026,64626,26325,62425,62417,16816,78715,64515,64516,87418,39817,48117,48117,19917,08515,386015,00914,22510,70613,06312,65511,90110,39110,3918,0323,5883,3433,3433,3013,2914944945252514949484746454444424141000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue28
Cost of Revenue-16
Gross Profit1212
 
Operating Income (+$)
Gross Profit12
Operating Expense-7,275
Operating Income-7,263-7,263
 
Operating Expense (+$)
Research Development1,377
Selling General Administrative5,898
Selling And Marketing Expenses0
Operating Expense7,2757,275
 
Net Interest Income (+$)
Interest Income0
Interest Expense-514
Other Finance Cost-9
Net Interest Income-505
 
Pretax Income (+$)
Operating Income-7,263
Net Interest Income-505
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-7,777-6,749
EBIT - interestExpense = -514
-7,777
-7,263
Interest Expense514
Earnings Before Interest and Taxes (EBIT)0-7,263
Earnings Before Interest and Taxes (EBITDA)-7,263
 
After tax Income (+$)
Income Before Tax-7,777
Tax Provision-0
Net Income From Continuing Ops-8,509-7,777
Net Income-7,777
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses7,291
Total Other Income/Expenses Net-514505
 

Technical Analysis of Zivo Bioscience Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Zivo Bioscience Inc. The general trend of Zivo Bioscience Inc is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Zivo Bioscience Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Zivo Bioscience Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 7.9 < 8.99 < 10.21.

The bearish price targets are: 6.87 > 6.25 > 4.44.

Tweet this
Zivo Bioscience Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Zivo Bioscience Inc. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Zivo Bioscience Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Zivo Bioscience Inc. The current macd is 0.03260878.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Zivo Bioscience Inc price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Zivo Bioscience Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Zivo Bioscience Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Zivo Bioscience Inc Daily Moving Average Convergence/Divergence (MACD) ChartZivo Bioscience Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Zivo Bioscience Inc. The current adx is 31.87.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Zivo Bioscience Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Zivo Bioscience Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Zivo Bioscience Inc. The current sar is 10.14.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Zivo Bioscience Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Zivo Bioscience Inc. The current rsi is 43.38. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Zivo Bioscience Inc Daily Relative Strength Index (RSI) ChartZivo Bioscience Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Zivo Bioscience Inc. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Zivo Bioscience Inc price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Zivo Bioscience Inc Daily Stochastic Oscillator ChartZivo Bioscience Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Zivo Bioscience Inc. The current cci is -191.56193136.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Zivo Bioscience Inc Daily Commodity Channel Index (CCI) ChartZivo Bioscience Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Zivo Bioscience Inc. The current cmo is -35.44568784.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Zivo Bioscience Inc Daily Chande Momentum Oscillator (CMO) ChartZivo Bioscience Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Zivo Bioscience Inc. The current willr is -56.88073394.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Zivo Bioscience Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Zivo Bioscience Inc Daily Williams %R ChartZivo Bioscience Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Zivo Bioscience Inc.

Zivo Bioscience Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Zivo Bioscience Inc. The current atr is 0.82483193.

Zivo Bioscience Inc Daily Average True Range (ATR) ChartZivo Bioscience Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Zivo Bioscience Inc. The current obv is -557,808.

Zivo Bioscience Inc Daily On-Balance Volume (OBV) ChartZivo Bioscience Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Zivo Bioscience Inc. The current mfi is 42.36.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Zivo Bioscience Inc Daily Money Flow Index (MFI) ChartZivo Bioscience Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Zivo Bioscience Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-17STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-24STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-13WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-10ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-22ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-23CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Zivo Bioscience Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Zivo Bioscience Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.375
Ma 20Greater thanMa 508.607
Ma 50Greater thanMa 1008.377
Ma 100Greater thanMa 2005.056
OpenGreater thanClose7.680
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Zivo Bioscience Inc with someone you think should read this too:
  • Are you bullish or bearish on Zivo Bioscience Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Zivo Bioscience Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Zivo Bioscience Inc

I send you an email if I find something interesting about Zivo Bioscience Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Zivo Bioscience Inc.

Receive notifications about Zivo Bioscience Inc in your mailbox!